OSTEOPALplus-使用说明书-Heraeus.PDF

Radiopaque bone cement for filling and stabilising vertebral bodies with an extended application time OSTEOPAL® plus EN Instructions for use 3 Working times 6 (Revision status: 2016-11) ZH 使用说明书 7 加工时间 9 (修订状态: 2016-11) 07471 2 MM/JJ EN OSTEOPAL® plus Properties Side effects ® OSTEOPAL plus is a radiopaque, low-viscosity bone There are frequent reports of a temporary reduction in cement, based on polymethylmethacrylate with an blood pressure immediately after implantation of PMMA extended application phase, used to fill and stabilise bone cements. Less frequent cases of hypotension accom- vertebral bodies. panied by anaphylaxis have been described; including ® OSTEOPAL plus contains zirconium dioxide as an X-ray anaphylactic shock, cardiac arrest and sudden death. contrast agent. The colouring agent chlorophyll (E141) is These cardiovascular and respiratory side effects, also ® mixed with OSTEOPAL plus to improve visibility of the known as implantation syndrome or bone cement syn- surgical field. drome, result from infiltration of bone marrow components The bone cement is prepared immediately prior to use by into the venous vascular system. In the case of pulmonary mixing the polymer powder component and the liquid or cardiovascular complications, monitoring and possibly monomer component. A low